110 related articles for article (PubMed ID: 11072592)
1. The effect of promoter strength in adenoviral vectors in hyperplastic synovium.
Goossens PH; Schouten GJ; Heemskerk B; 't Hart BA; Bout A; Kluin PM; Breedveld FC; Valerio D; Huizinga TW
Clin Exp Rheumatol; 2000; 18(5):547-52. PubMed ID: 11072592
[TBL] [Abstract][Full Text] [Related]
2. Specific targeting of pancreatic islet cells in vivo by insulin-promoter-driven adenoviral conjugated reporter genes.
Wang X; Olmsted-Davis E; Davis A; Liu S; Li Z; Yang J; Brunicardi FC
World J Surg; 2006 Aug; 30(8):1543-52. PubMed ID: 16855800
[TBL] [Abstract][Full Text] [Related]
3. The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.
Peng XY; Won JH; Rutherford T; Fujii T; Zelterman D; Pizzorno G; Sapi E; Leavitt J; Kacinski B; Crystal R; Schwartz P; Deisseroth A
Cancer Res; 2001 Jun; 61(11):4405-13. PubMed ID: 11389068
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of adenovirus-mediated nonsurgical synovectomy in collagen-induced arthritis-affected rhesus monkeys.
Goossens PH; Schouten GJ; 't Hart BA; Bout A; Brok HP; Kluin PM; Breedveld FC; Valerio D; Huizinga TW
Hum Gene Ther; 1999 May; 10(7):1139-49. PubMed ID: 10340546
[TBL] [Abstract][Full Text] [Related]
5. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.
Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB
Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877
[TBL] [Abstract][Full Text] [Related]
6. Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis.
Goater J; Müller R; Kollias G; Firestein GS; Sanz I; O'Keefe RJ; Schwarz EM
J Rheumatol; 2000 Apr; 27(4):983-9. PubMed ID: 10782827
[TBL] [Abstract][Full Text] [Related]
7. The effect of apoptosis signal-regulating kinase 1 gene transfer on rat collagen induced arthritis.
Terauchi R; Arai Y; Takahashi KA; Inoue A; Tonomura H; Asada H; Kishida T; Imanishi J; Mazda O; Kitajima I; Kubo T
J Rheumatol; 2005 Dec; 32(12):2373-80. PubMed ID: 16331767
[TBL] [Abstract][Full Text] [Related]
8. Intraocular adenoviral vector-mediated gene transfer in proliferative retinopathies.
Mori K; Gehlbach P; Ando A; Wahlin K; Gunther V; McVey D; Wei L; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1610-5. PubMed ID: 11980881
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
10. Efficient adenovirus-mediated gene expression in malignant human plasma cells: relative lymphoid cell resistance.
Prince HM; Dessureault S; Gallinger S; Krajden M; Sutherland DR; Addison C; Zhang Y; Graham FL; Stewart AK
Exp Hematol; 1998 Jan; 26(1):27-36. PubMed ID: 9430511
[TBL] [Abstract][Full Text] [Related]
11. Adenoviral-mediated gene transfer to rabbit synovium in vivo.
Roessler BJ; Allen ED; Wilson JM; Hartman JW; Davidson BL
J Clin Invest; 1993 Aug; 92(2):1085-92. PubMed ID: 8349791
[TBL] [Abstract][Full Text] [Related]
12. Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo.
Nita I; Ghivizzani SC; Galea-Lauri J; Bandara G; Georgescu HI; Robbins PD; Evans CH
Arthritis Rheum; 1996 May; 39(5):820-8. PubMed ID: 8639179
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene.
Esandi MC; van Someren GD; Vincent AJ; van Bekkum DW; Valerio D; Bout A; Noteboom JL
Gene Ther; 1997 Apr; 4(4):280-7. PubMed ID: 9176512
[TBL] [Abstract][Full Text] [Related]
14. Characterization of promoter function and cell-type-specific expression from viral vectors in the nervous system.
Smith RL; Traul DL; Schaack J; Clayton GH; Staley KJ; Wilcox CL
J Virol; 2000 Dec; 74(23):11254-61. PubMed ID: 11070024
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the specificity and activity of a cellular promoter in an adenoviral vector.
Shi Q; Wang Y; Worton R
Hum Gene Ther; 1997 Mar; 8(4):403-10. PubMed ID: 9054515
[TBL] [Abstract][Full Text] [Related]
16. Efficient gene transfer into mouse embryonic stem cells with adenovirus vectors.
Kawabata K; Sakurai F; Yamaguchi T; Hayakawa T; Mizuguchi H
Mol Ther; 2005 Sep; 12(3):547-54. PubMed ID: 15950541
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
[TBL] [Abstract][Full Text] [Related]
18. Direct exposure of mouse ovaries and oocytes to high doses of an adenovirus gene therapy vector fails to lead to germ cell transduction.
Gordon JW
Mol Ther; 2001 Apr; 3(4):557-64. PubMed ID: 11319918
[TBL] [Abstract][Full Text] [Related]
19. Sustained expression of human apolipoprotein A-I after adenoviral gene transfer in C57BL/6 mice: role of apolipoprotein A-I promoter, apolipoprotein A-I introns, and human apolipoprotein E enhancer.
De Geest B; Van Linthout S; Lox M; Collen D; Holvoet P
Hum Gene Ther; 2000 Jan; 11(1):101-12. PubMed ID: 10646643
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
